Reina Hoshi

Reina Hoshi

Auto-generated profile, based on publicly available information

Reina Hoshi

Department of Pediatric Surgery Nihon University School of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
KSKiminobu Sugito
Kiminobu Sugito
HKHiroyuki Kawashima
Hiroyuki Kawashima
SYShinsuke Yoshizawa
Shinsuke Yoshizawa
SUShota Uekusa
Shota Uekusa
RHReina Hoshi
Reina Hoshi
HNHiroki Nagase
Hiroki Nagase

1 January 2022 in Pediatrics International
Verified
Journal Article
Closed access
RHReina Hoshi
Reina Hoshi
SUShuichiro Uehara
Shuichiro Uehara
THTakashi Hosokawa
Takashi Hosokawa
HKHide Kaneda
Hide Kaneda
TKTsugumichi Koshinaga
Tsugumichi Koshinaga

15 February 2019 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
RHReina Hoshi
Reina Hoshi
SUShuichiro Uehara
Shuichiro Uehara
KOKako Ono
Kako Ono
KOKensuke Ohashi
Kensuke Ohashi
TKTsugumichi Koshinaga
Tsugumichi Koshinaga

1 January 2022 in Pediatrics International
Verified
Journal Article
Closed access
RHReina Hoshi
Reina Hoshi
SUShuichiro Uehara
Shuichiro Uehara
TFTakeshi Furuya
Takeshi Furuya
HKHide Kaneda
Hide Kaneda
TKTsugumichi Koshinaga
Tsugumichi Koshinaga

27 August 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
RHReina Hoshi
Reina Hoshi
SUShuichiro Uehara
Shuichiro Uehara
MHMakoto Hashimoto
Makoto Hashimoto
THTakashi Hosokawa
Takashi Hosokawa
HKHiroyuki Kawashima
Hiroyuki Kawashima
TKTsugumichi Koshinaga
Tsugumichi Koshinaga

9 September 2025 in Cancer Reports
Verified
Journal Article
Open access
THTakayuki Hirano
Takayuki Hirano
RHReina Hoshi
Reina Hoshi
BYBin Yamaoka
Bin Yamaoka
KOKako Ono
Kako Ono
YWYosuke Watanabe
Yosuke Watanabe
SUShuichiro Uehara
Shuichiro Uehara
Background: Alpha‐fetoprotein (AFP)‐producing gastric cancer (AFPGC) is resistant to chemotherapy and is associated with poor prognosis. Pediatric gastric cancer has an incidence of 0.02% among gastric cancer patients, with a median survival of 5 months.Case: A 13‐year‐old boy presented with progressive dysphagia for 2 months, accompanied by loss of appetite and significant weight loss. Liver dysfunction and multiple lesions were observed. Laboratory investigations revealed elevated liver enzymes and tumor markers, including AFP, at 24 502 ng/mL. Computed tomography (CT) showed thickening of the gastric cardia and multiple liver lesions. Upper gastrointestinal endoscopy revealed a type 2 tumor in the cardia. Histopathology confirmed adenocarcinoma, and immunohistochemical staining was positive for AFP, establishing a diagnosis of AFPGC with liver metastases (Stage IV). Given the unresectable and HER2‐negative nature of the cancer, chemotherapy with TS‐1 and cisplatin was initiated, resulting in a temporary reduction in AFP levels and tumor size. However, disease progression was noted after 3 months, requiring a switch in treatment to ramucirumab, paclitaxel, bleomycin, etoposide, cisplatin, or a study drug. Despite these efforts, the patient succumbed to the disease 16 months after initial treatment.Conclusion: AFPGC in children is extremely rare, with few reported cases. The 16‐month survival observed in this case exceeds previously reported durations (8 and 4 months). Systematic evaluation of persistent gastrointestinal symptoms enabled earlier diagnosis. Standard adult gastric cancer treatment protocols appeared more effective than AFP‐tumor‐specific regimens, suggesting they may be optimal for pediatric AFPGC as well. Early diagnosis through detailed history‐taking and prompt endoscopic examinations in children with gastrointestinal symptoms may lead to significantly prolonged survival and improved management in this rare malignancy.